Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 Study.

Stewart, IORCID logo; Jacob, JORCID logo; George, PMORCID logo; Molyneaux, PLORCID logo; Porter, JCORCID logo; Allen, RJ; Aslani, S; Baillie, JKORCID logo; Barratt, SL; Beirne, P; +68 more...Bianchi, SM; Blaikley, JFORCID logo; Chalmers, JD; Chambers, RCORCID logo; Chadhuri, N; Coleman, C; Collier, G; Denneny, EKORCID logo; Docherty, A; Elneima, O; Evans, RAORCID logo; Fabbri, L; Gibbons, MA; Gleeson, FV; Gooptu, B; Greening, NJ; Guio, BG; Hall, IPORCID logo; Hanley, NA; Harris, V; Harrison, EM; Heightman, M; Hillman, TE; Horsley, AORCID logo; Houchen-Wolloff, L; Jarrold, I; Johnson, SRORCID logo; Jones, MG; Khan, F; Lawson, R; Leavy, O; Lone, N; Marks, MORCID logo; McAuley, HORCID logo; Mehta, P; Parekh, D; Hanley, KP; Platé, M; Pearl, J; Poinasamy, K; Quint, JKORCID logo; Raman, BORCID logo; Richardson, M; Rivera-Ortega, P; Saunders, L; Saunders, R; Semple, MG; Sereno, M; Shikotra, A; Simpson, AJ; Singapuri, A; Smith, DJ; Spears, M; Spencer, LG; Stanel, S; Thickett, DRORCID logo; Thompson, ARORCID logo; Thorpe, M; Walsh, SL; Walker, S; Weatherley, ND; Weeks, ME; Wild, JM; Wootton, DG; Brightling, CE; Ho, L; Wain, LVORCID logo; Jenkins, GRORCID logo and (2023) Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 Study. American journal of respiratory and critical care medicine, 207 (6). pp. 693-703. ISSN 1073-449X DOI: 10.1164/rccm.202203-0564OC
Copy

Rationale: Shared symptoms and genetic architecture between coronavirus disease (COVID-19) and lung fibrosis suggest severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may lead to progressive lung damage. Objectives: The UK Interstitial Lung Disease Consortium (UKILD) post-COVID-19 study interim analysis was planned to estimate the prevalence of residual lung abnormalities in people hospitalized with COVID-19 on the basis of risk strata. Methods: The PHOSP-COVID-19 (Post-Hospitalization COVID-19) study was used to capture routine and research follow-up within 240 days from discharge. Thoracic computed tomography linked by PHOSP-COVID-19 identifiers was scored for the percentage of residual lung abnormalities (ground-glass opacities and reticulations). Risk factors in linked computed tomography were estimated with Bayesian binomial regression, and risk strata were generated. Numbers within strata were used to estimate posthospitalization prevalence using Bayesian binomial distributions. Sensitivity analysis was restricted to participants with protocol-driven research follow-up. Measurements and Main Results: The interim cohort comprised 3,700 people. Of 209 subjects with linked computed tomography (median, 119 d; interquartile range, 83-155), 166 people (79.4%) had more than 10% involvement of residual lung abnormalities. Risk factors included abnormal chest X-ray (risk ratio [RR], 1.21; 95% credible interval [CrI], 1.05-1.40), percent predicted DlCO less than 80% (RR, 1.25; 95% CrI, 1.00-1.56), and severe admission requiring ventilation support (RR, 1.27; 95% CrI, 1.07-1.55). In the remaining 3,491 people, moderate to very high risk of residual lung abnormalities was classified at 7.8%, and posthospitalization prevalence was estimated at 8.5% (95% CrI, 7.6-9.5), rising to 11.7% (95% CrI, 10.3-13.1) in the sensitivity analysis. Conclusions: Residual lung abnormalities were estimated in up to 11% of people discharged after COVID-19-related hospitalization. Health services should monitor at-risk individuals to elucidate long-term functional implications.


picture_as_pdf
Stewart-etal-2023-Residual-lung-abnormalities-after-covid.pdf
subject
Published Version
Available under Creative Commons: Attribution 4.0

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads